A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission

Clinical trial NCT01632852 · COMPLETED

Trial details

NCT number: NCT01632852
Sponsor: CSL Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2012-07-01
Primary completion: 2015-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.